YingXing Wu, MD, Gary L. Grunkemeier, PhD, Albert Starr, MD

Slides:

Advertisements

Similar presentations

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Advertisements

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Of mice and men and surgical transcatheter aortic valve insertion

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

A cherry blossom moment in the history of heart valve replacement

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Endoscopic Robotic Mitral Valve Surgery

“Lead from the front”: Participative leadership

YingXing Wu, MD, Ruyun Jin, MD, Guangqiang Gao, MD, Gary L

Replacement of the ascending aorta in bicuspid aortic valve disease: Where do we draw the line? Thoralf M. Sundt, MD The Journal of Thoracic and Cardiovascular.

Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society.

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Form ever follows function

William M. DeCampli, MD, PhD

Go on-pump or off-pump in diabetic patients?

Quadruple valve replacement in patients with carcinoid heart disease

Bicuspid aortic valve aortopathy: One size fits all?

Roland Assi, MD, MMS, Wilson Y. Szeto, MD

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery Pedro J.

The variability of the mitral valve anatomy and terminology

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Michele Gallo, MD, Gino Gerosa, MD

A first start for lung transplantation?

The aortic valve–sparing operation

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Torsten Doenst, MD, PhD, Markus Richter, MD

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

The Journal of Thoracic and Cardiovascular Surgery

A cherry blossom moment in the history of heart valve replacement

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Sinus of Valsalva aneurysms: Stabilizing the repair destabilizing the aortic valve? M. Sertaç Çiçek, MD, FACC The Journal of Thoracic and Cardiovascular.

In search of the smoking gun in calcific aortic valve disease

Replicating the success of mitral valve repair in the aortic valve

A fate worse than death Jennifer S. Lawton, MD

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

Taking UP the chronic pulmonary obstructive disease gauntlet

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Biomaterials for heart valve replacement: Conjectures and refutations

The Mitroflow aortic valve: A past, present, and future illuminated

Hans-Joachim Schäfers, MD

Ralph S. Mosca, MD The Journal of Thoracic and Cardiovascular Surgery

Transcatheter aortic valve replacement for prime time unrestricted distribution? Not so fast, my friend G. Michael Deeb, MD, John Carroll, MD The Journal.

Concomitant replacement of the ascending aorta is free—for some

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tissue valve, nitinol stent, or storage solution

The future of cardiac surgery training: A survival guide

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

The continuing challenge of congenital heart disease in China

Commentary: When a choice is not an echo

Between a rock and a hard place

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

“The more things change…”: The challenges ahead

Toward a more rational approach in treating type B aortic dissection

Evaluating the best approach to treatment of aortic stenosis: The jury is still out Glen B. Taksler, PhD The Journal of Thoracic and Cardiovascular Surgery

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Did you like Terminator 3 better than Terminator 2

Durability of pericardial versus porcine bioprosthetic heart valves

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Presentation transcript:

The value of aortic valve replacement in elderly patients: An economic analysis YingXing Wu, MD, Gary L. Grunkemeier, PhD, Albert Starr, MD The Journal of Thoracic and Cardiovascular Surgery Volume 133, Issue 3, Pages 603-607 (March 2007) DOI: 10.1016/j.jtcvs.2006.08.042 Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Age-adjusted death rates by major cause of death, United States, 1960-2003. Source data from US National Center for Health Statistics.2 Other disease category includes chronic lower respiratory diseases, diabetes mellitus, influenza, pneumonia, chronic liver disease, and cirrhosis. The Journal of Thoracic and Cardiovascular Surgery 2007 133, 603-607DOI: (10.1016/j.jtcvs.2006.08.042) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Value of life-year by age in 2005 dollars, as derived from Murphy and Topel.3 The Journal of Thoracic and Cardiovascular Surgery 2007 133, 603-607DOI: (10.1016/j.jtcvs.2006.08.042) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Total life-years after aortic valve replacement (light gray bar) and natural history (dark gray bar) by age at surgery. AVR, aortic valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2007 133, 603-607DOI: (10.1016/j.jtcvs.2006.08.042) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Average net value gained after aortic valve replacement by age at surgery (gray bar). Error bars indicate 95% range from 1000 times simulation. AVR, aortic valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2007 133, 603-607DOI: (10.1016/j.jtcvs.2006.08.042) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions